DAVITA INC. Marketable Securities (Current)
DAVITA INC. (DVA) had Marketable Securities (Current) of $19.91 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-08-04
- 2026-06-30: Marketable Securities, Current $19.91M.
- 2026-03-31: Marketable Securities, Current $22.30M.
- 2025-12-31: Marketable Securities, Current $24.30M.
- 2025-09-30: Marketable Securities, Current $30.52M.
| Period end | Marketable Securities, Current | Marketable Securities, Current as first filed |
|---|---|---|
| 2026-06-30 | $19.91M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $22.30M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $24.30M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $30.52M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $31.01M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $73.16M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $51.06M 10-K · filed 2026-02-11 | |
| 2024-09-30 | $21.00M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $20.69M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $10.61M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $11.61M 10-K · filed 2025-02-13 | |
| 2023-09-30 | $11.71M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $12.48M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $49.97M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $77.69M 10-K · filed 2024-02-14 | |
| 2022-09-30 | $74.31M 10-Q · filed 2022-10-31 | |
| 2022-06-30 | $100.49M 10-Q · filed 2022-08-01 | |
| 2022-03-31 | $19.41M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $22.31M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $26.69M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $36.70M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $11.06M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $20.10M 10-K · filed 2022-02-11 | |
| 2020-09-30 | $19.36M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $154.12M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $9.38M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $11.57M 10-K · filed 2021-02-12 | |
| 2019-09-30 | $100.71M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $5.21M 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $4.04M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $2.94M 10-K · filed 2020-02-21 | |
| 2018-09-30 | $4.73M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $4.53M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $4.60M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $32.83M 10-K · filed 2019-02-22 | $43.52M 10-K · filed 2018-02-23 |
| 2017-09-30 | $137.36M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $211.44M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $313.26M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $306.98M 10-K · filed 2018-02-23 | $310.20M 10-K · filed 2017-02-24 |
| 2016-09-30 | $659.48M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $394.17M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $396.47M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $408.08M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $922.85M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $942.14M 10-Q · filed 2015-08-05 | |
| 2014-12-31 | $337.40M 10-K · filed 2016-02-26 | |
| 2013-12-31 | $6.80M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |